At $329.23, International Business Machines (NYSE:IBM | IBM Price Prediction) trades well above the roughly $260 level that some value-oriented frameworks would flag as a more compelling entry point. The stock has climbed 31.33% in one week and 42.83% in one month, rewarding owners and punishing those chasing the rally.
Big Blue has shed its legacy hardware drag. Software now anchors the model at $7.05 billion in Q1 2026 revenue, up 11.3%, with Data up 19%. Infrastructure rode an IBM Z refresh to 15.3% growth, with the mainframe surging 51% and segment margin expanding from 8.6% to 15.8%.
Why The Bull Case Looks Loaded
Full-year 2025 free cash flow reached $14.73 billion, and management guides to roughly $1 billion incremental FCF lift in 2026 on 5% plus constant currency revenue growth. Software annual recurring revenue stands at $24.6 billion, up 10% year over year.
The generative AI book of business vaulted from $7.5 billion to $12.5 billion inception-to-date in three quarters. CEO Arvind Krishna framed it plainly: “AI continues to be a tailwind for our global business.” Four straight EPS beats and a 31st consecutive dividend hike round out the case.
Why The Recent 31% Week Complicates The Entry
The bear case is purely valuation. IBM trades at a trailing P/E of 28, a forward P/E of 26, and a PEG near 3. That is a premium multiple for a company whose Consulting segment grew just 4% and whose mainframe boom is cyclical by definition.
Total debt climbed to $61.3 billion after the Confluent acquisition. The stock traveled from $314.84 in January to $257.80 by April, a reminder that volatility lives in this name despite a 0.581 beta.
The Patience Trade
Holding reflects honest uncertainty. The fundamentals support a constructive view, while the price after a vertical six-week move complicates fresh entries. The 50-day moving average sits at $240.63 and the 200-day at $270.89, both well below the current quote.
A pullback to roughly $260 would materially improve the valuation setup. A Consulting deceleration, an AI book that stalls, or a clear mainframe rolloff would weaken the thesis. Each quarter the watch list is the same: Software ARR and the GenAI book.
The Numbers Backing The Wait
IBM currently trades at $329.23 against a consensus analyst price target of $285.89, implying roughly 13% downside to the average target. Coverage spans 21 analysts, with 1 Strong Buy, 11 Buy, 7 Hold, 0 Sell, and 2 Strong Sell. Targets are one input among many.
Year to date, IBM is up 12.61% versus the S&P 500 at 11.39%. Over one year, IBM returned 27.97% against the index’s 28.15%, a virtual tie. The 52-week range runs $212.34 to $332.41, putting today within a hair of the high. Market cap sits near $301 billion with a 2.26% dividend yield.
Why $260 Is The Absolute Buy
At $329.23, IBM screens as fully valued.
The business is firing on every cylinder: Software ARR compounding, mainframe Z driving outsized Infrastructure profit, a GenAI book that grew $5 billion in three quarters, and FCF guided up another $1 billion. The operating results support the long-term ownership thesis.
Buying after a 31.33% one-week move chases a price that has already lapped analyst consensus. A revisit toward $260, near the 200-day average and the level that held in April, would compress the forward multiple to the low 20s and restore a margin of safety. That is where the dividend yield, FCF ramp, and AI optionality compound for the buyer rather than the seller.
The cost of patience is the dividend forgone and the risk that the rally extends. The cost of chasing is buying the top tick of a parabolic move in a name with cyclical infrastructure exposure. A retracement toward $260 would reset the risk/reward profile for prospective buyers.
Top Gaining Stocks
Top Losing Stocks